Parallel Advisors, LLC Lyra Therapeutics, Inc. Call Options Transaction History

Parallel Advisors, LLC

  • $5.28 Billion
  • Q3 2025

Call Options

1 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Oct 22, 2021
BUY
$6.06 - $9.43 $60 - $94
10 New
10 $0

Others Institutions Holding LYRA

# of Institutions
2
Shares Held
2.84M
Call Options Held
0
Put Options Held
0
View Full List

About Lyra Therapeutics, Inc.

LYRA Quotes by TradingView
  • Ticker LYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,826,400
  • Market Cap $124M
  • Description
  • Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...
More about LYRA
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email